Edit
Rgenix.com
http://www.rgenix.com/Last activity: 10.10.2018
Probably Closed - Reference to Mercusuar
Welcome to rgenix.com
Location: United States, New York
Employees: 11-50
Phone: +52 228 113 7424
Total raised: $73M
Founded date: 2010
Investors 3
| Date | Name | Website |
| - | Sofinnova ... | sofinnovap... |
| - | Exor | exor.com |
| - | Start Capi... | start-capi... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 09.10.2018 | Series C | $40M | - |
| 15.06.2016 | Series B | $33M | - |
Mentions in press and media 8
| Date | Title | Description |
| 10.10.2018 | Term Sheet — Wednesday, October 10 | 5 Qs WITH A DEALMAKER Good morning, Term Sheet readers. Paid Content What you need to know about growing cyberattacks From ExtraHop “We’ve backed quite a few companies that have started as accidental businesses,” Court told Term Sheet. “The... |
| 09.10.2018 | Novartis plans to open a string of global digital labs; Rgenix snags a $40M round in push toward PhII | → Vas Narasimhan has made no secret of his keen interest in making Novartis over with new digital technologies, and now he plans to open new offices around the world to help cement ties with a host of players in the field, from... |
| 09.10.2018 | Rgenix Raises $40M in Series C Funding | Rgenix, Inc., a NYC-based clinical stage biopharmaceutical company developing small molecule and antibody cancer therapeutics, raised $40m in Series C financing. The round was led by Lepu Medical, a publicly traded global healthcare firm, a... |
| 09.10.2018 | Rgenix Grabs $40M Series C Financing | NEW YORK, NY, Rgenix announced that it has raised $40 million in a Series C financing. >> Click here for more funding data on Rgenix >> To export Rgenix funding data to PDF and Excel, click here Rgenix, a clinical stage b... |
| 09.10.2018 | Rgenix Raises $40M in Series C Funding | NEW YORK--(BUSINESS WIRE)--Rgenix, Inc., a clinical stage biopharmaceutical company developing first-in-class small molecule and antibody cancer therapeutics, announced that it has raised $40 million in a Series C financing in support of fu... |
| 15.06.2016 | Rgenix Raises $33 Million Series B | NEW YORK--(BUSINESS WIRE)--Rgenix, a cancer therapeutics company developing first-in-class drugs targeting novel cancer pathways, announced a $33 million Series B financing led by Novo A/S and Sofinnova Partners, with participation from exi... |
| 15.06.2016 | Rgenix Announces $33M Series B | NEW YORK, NY, Cancer therapeutics company developing first-in-class drugs targeting novel cancer pathways, announced a $33 million Series B financing. >> Click here for more funding data on Rgenix >> To export Rgenix funding... |
| 15.06.2016 | NYC-Based Cancer Therapeutics Company Rgenix Raises $33M in Series B Funding | Rgenix, a NYC-based cancer therapeutics company developing drugs targeting novel cancer pathways, raised $33m in Series B financing. The round was led by Novo A/S and Sofinnova Partners, with participation from existing investors including ... |